Medical Access in Ethiopia

Currently classified as a strictly controlled psychotropic/narcotic-type substance under Ethiopia's implementation of UN conventions and national drug control law; there is no authorized medical use or reimbursed access outside of approved clinical research. The Criminal Code and national drug proclamations criminalize production, possession, use or trafficking of narcotic and psychotropic substances without special authorization, and Ethiopia's regulatory framework places scheduling and registration authority with the national medicines regulator. [1]Criminal Code Art.525 [2]Drug Administration & Control Proclamation No.176/1999

Currently classified as a strictly controlled psychotropic/narcotic-type substance under Ethiopia's implementation of UN conventions and national drug control law; there is no authorized medical use or reimbursed access outside of approved clinical research. The Criminal Code and national proclamations criminalize unauthorized activities involving psychotropic substances; any research or import requires explicit authorization from the national regulator. [1]Criminal Code Art.525 [2]Drug Administration & Control Proclamation No.176/1999

Esketamine (brand products such as Spravato) does not appear in publicly available records as an approved, registered psychiatric treatment with a reimbursed pathway in Ethiopia; novel antidepressant formulations require product registration and market authorization by the national regulator (EFDA) under the medicines regulatory framework, and there is no evidence of a national program or public reimbursement for esketamine. The national regulator (EFDA) is the competent authority for medicine registration and ensures that medicines are authorized before clinical or reimbursed use. For approved/registered medicines in Ethiopia, public procurement and inclusion on national formularies determine reimbursement; no published national formulary or regulator announcement indicates esketamine registration or reimbursement at this time. [1]EFDA - Ethiopia [2]Drug Administration & Control Proclamation No.176/1999

Ketamine is an established, registered anesthetic and analgesic that is used in Ethiopian hospitals and surgical settings; it is part of the conventional essential medicine supply used in clinical care although availability and consistent supply in public facilities are constrained in parts of the country. National-level medicine availability surveys and facility studies document use of conventional anesthetics and note limited availability of many psychotropic medicines in public hospitals, while ketamine is used clinically for anesthesia in resource-limited settings. Public reimbursement for routine anesthetic drugs is determined through government procurement and hospital formularies; there is no formal, nationally reimbursed outpatient psychiatric ketamine program for depression (i.e., ketamine infusions for mental health are not an established reimbursed indication). Off-label psychiatric use (e.g., for treatment-resistant depression) would require local hospital policy, clinician prescription, and likely private payment or ad hoc hospital funding rather than a national reimbursement pathway. [1]Availability, Price and Affordability of Psychotropic Medicines in Addis Ababa [2]EFDA - Ethiopia [3]Criminal Code Art.525

Currently classified as a strictly controlled psychotropic/narcotic-type substance under Ethiopia's implementation of UN conventions and national drug control law; there is no authorized medical use or reimbursed access outside of approved clinical research. Possession, manufacture, importation or use without explicit authorization is criminalized. [1]Drug Administration & Control Proclamation No.176/1999 [2]Criminal Code Art.525

Currently classified as a strictly controlled psychotropic/narcotic-type substance under Ethiopia's implementation of UN conventions and national drug control law; there is no authorized medical use or reimbursed access outside of approved clinical research. Any research use would require formal approval from the national regulatory authority and relevant criminal-law exemptions. [1]Drug Administration & Control Proclamation No.176/1999 [2]Criminal Code Art.525

Currently classified as a strictly controlled psychotropic/narcotic-type substance under Ethiopia's implementation of UN conventions and national drug control law; there is no authorized medical use or reimbursed access outside of approved clinical research. There are no published national clinical programs or regulatory approvals enabling ibogaine therapy or reimbursement. [1]Drug Administration & Control Proclamation No.176/1999 [2]Criminal Code Art.525

Ayahuasca contains DMT and thus falls under the national prohibitions and controls applicable to DMT/psychotropic substances; there is no authorized medical, religious exemption, or reimbursed pathway for ayahuasca in Ethiopia outside of formally approved clinical research. Use, possession, importation, or distribution without authorization is criminalized under national drug control laws. [1]Criminal Code Art.525 [2]Drug Administration & Control Proclamation No.176/1999

Currently classified as a strictly controlled psychotropic/narcotic-type substance under Ethiopia's implementation of UN conventions and national drug control law; there is no authorized medical use or reimbursed access outside of approved clinical research. Possession or trafficking without authorization is subject to criminal penalties. [1]Criminal Code Art.525 [2]Drug Administration & Control Proclamation No.176/1999

Substituted phenethylamines of the 2C family (commonly addressed internationally as controlled psychotropic substances) would fall under Ethiopia's broad criminal prohibitions on psychotropic substances implemented pursuant to UN conventions; there is no authorized medical use or reimbursed access for 2C compounds outside approved research. The national criminal code criminalizes possession, manufacture, distribution or use without special authorization. [1]Criminal Code Art.525 [2]Drug Administration & Control Proclamation No.176/1999